Summary
To investigate the hypotensive and hemodynamic effects of plain and extended-release (ER) formulations of felodipine added to a diuretic in the treatment of moderate essential hypertension, we studied 18 patients in a randomized, double-blind, cross-over study. Blood pressure (BP), heart rate (HR), hemodynamics (bioimpedance), foot volume (Archimedes' principle), and symptoms were evaluated after a 1-month placebo washout, after 1-month's treatment with a fixed combination of hydrochlorothiazide 50 mg plus amiloride 5 mg (HA), and then after felodipine 5 mg twice daily (F) or felodipine ER 10 mg daily (FER) (double-blind phase), each given for 2 weeks in a randomized sequence together with the diuretic. All measurements were performed at the end of the dosing interval. At baseline, supine SBP/DBP was 175.6±12.9/113.4±8.1 mmHg; HR was 77.3±7.0 beats/min; CO was 5.3±1.4 l/min; SVR was 2166±707 dynes sec. cm5, and foot volume was 433±195 ml (FV). HA induced a reduction (p<0.05) in BP; one patient had a DBP=90 mmHg and was excluded from the combination study; eight patients had a DBP reduction of ≥10 mmHg (responders), and their blood pressure was mainly reduced by a fall in SVR. HR, CO, and FV were unchanged. The addition of felodipine to a diuretic induced a further significant (p<0.001) reduction in BP with respect to HA alone, with no differences between F and FER. All patients had a DBP fall >10 mmHg, which had no relationship to their response to the diuretic. The antihypertensive effect of felodipine was due to a reduction in SVR (p<0.05). CO and HR were significantly (p>0.05) increased by felodipine added to HA. FV was increased by felodipine. During felodipine treatment, side effects were significantly decreased in comparison with placebo. Thus, a once-daily administration of 10 mg extended-release felodipine was equieffective with felodipine 5 mg twice daily in hypertensives who were sufficiently controlled by diuretic alone. The antihypertensive effect of felodipine is due to a reduction in SVR and is not prevented by diuretic treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, evaluation and treatment of high blood pressure.Arch Intern Med 1988;148:1023–1038.
de Divitiis O, Di Somma S, Petitto M, et al. Muzolimine and nitrendipine in the treatment of arterial hypertension.Zeitschrift fur Kardiologie 1985;74(Suppl 2):60–65.
de Divitiis O, Petitto M, Di Somma S, et al. Atenolol, chlorthalidone and reserpine in mild-moderate hypertension: Double-blind comparison.Drug Exper Clin Res 1981;7:773–779.
Magagna A, Abdel-Haq B, Pedrinelli R, Salvetti A. Does chlorothiazide increase hypotensive effects of nifedipine?J Hypertens 1986;4(Suppl 5):519–521.
Erne P, Bolli P, Beutel O, et al. Factors influencing the hypotensive effect of calcium antagonists.Hypertension 1984;2(Suppl 3):449–452.
Resnick LM, Nicholson JP, Laragh JH. Calcium metabolism and the renin aldosterone system in essential hypertension.J Cardiovasc Pharmacol 1985;7:S187–S193.
Leonetti G, Zanchetti A. Renal effect of calcium antagonists in hypertensive patients.J Hypertens 1985;3(Suppl 3):535–539.
Lijung B. Vascular selectivity of felodipine.Drugs 1985; 29(Suppl 2):46–58.
Di Bona GF, Sawin LL. Renal tabular site of action of felodipine.J Pharmacol Exp Ther 1984;228:420–424.
Sluiter HE, Huysmans FTM, Thien TA, Koene RAP. Haemodynamic effects of intravenous felodipine in normotensive and hypertensive subjects.Drugs 1985;29(Suppl 2): 144–53.
Elmfeldt D, Hedner T, Westerling S. Felodipine in hypertension.Rer J Cardivasc Pharmacol 1987;10(Suppl I):S154–S160.
Collste P, Danielsson M, Elmfeldt D. Long-term experience of felodipine in combination with beta-blocker and diuretics in refractory hypertension.Drugs 1985;29(Suppl 2):124–130.
Sluiter HE (on behalf of The Dutch Multicentre Study Group). Felodipine in hypertensive patients: Dose finding study in patients refractory to beta-blocker monotherapy.Drugs 1987;34(Suppl 3):97–106.
Hedner T, Elmfeldt D, Dahloef C, Sjoegren E. Comparison of antihypertensive effects and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension.Drugs 1987;34(Suppl 3):125–131.
Spinale FG, Reines HD, Crawford FA Jr. Comparison of bioimpedance and thermodilution methods for determining cardiac output: Experimental and clinical studies. Am Thorac Surg 1988;45:421–425.
Bernstein DP. Continuous noninvasive real time monitoring of stroke volume and cardiac output by thoracic electrical bioimpedance.Crit Care Med 1986;14:898–910.
Buell JC. A practical cost-effective noninvasive system for cardiac output and haemodynamic analysis.Am Heart J 1988;116:657–664.
Appel PL, Kram HB, MacKabee J, et al. Comparison of measurement of cardiac output by bioimpedance and thermodilution in severely ill surgical patients.Crit Care Med 1986;14:933–935.
de Divitiis O, Di Somma S, Liguori V, et al. Effort blood pressure control in the course of antihypertensive treatment.Am J Med 1989;87(Suppl 3C):46S-56S.
Linde M, Ohmhaus EE, Kirch W. Mechanism and impedance cardiography parameters in patients with heart failure in administration of a calcium-antagonist. The significance of the Heather index.Z Kardiol 1989;78:181–186.
Eisenberg BM, Linss G, Vollmar R. Comparative estimation of central haemodynamics during dynamic lead by impedance cardiography and radiocardiography.Cor Vasa 1988;30:285–291.
Tobian L. Why do thiazide diuretics lower blood pressure in essential hypertension?Ann Rev Pharmacol 1967;7:319–408.
Conway J. Haemodynamic effects of long term therapy with chlorothiazide.Circulation 1960;21:21–27.
Edgar B, Collste P, Haglund K, Regardh CG. Pharmacokinetics and haemodynamic effects of felodipine or monotherapy in hypertensive patients.Clin Invest Med 1987;10:388–394.
Edgar B, Lundborg P, Regardh CG. Clinical pharmacokinetics of felodipine. A summary.Drugs 1987;34 (Suppl 3):16–27.
Hart W, Westberg B, for the Dutch Hospital Multicentre Group. Felodipine extended release tablets once daily versus plain tablets twice daily in hypertension. In:Plendil in Hypertension International Symposium. Rome 17–18 October, 1988.
de Divitiis O, Petitto M, Di Somma S, et al. Nitrendipine and atenolol: Comparison and combination in the treatment of arterial hypertension.Arzneimittel Forschung (Drug Res) 1985;35:727–729.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Di Somma, S., Liguori, V., Petitto, M. et al. Hemodynamic interactions between diuretics and calcium antagonists in the treatment of hypertensive patients. Cardiovasc Drug Ther 4, 1151–1156 (1990). https://doi.org/10.1007/BF01856512
Issue Date:
DOI: https://doi.org/10.1007/BF01856512